Flemming Steen Jørgensen

Citeret af

	Alle	Siden 2017
Henvisninger	3480	929
h-index	31	18
i10-indeks	72	35

200

100

150

198319841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202215 16 7 14 6 11 17 28 32 34 34 37 38 29 40 38 34 42 45 53 69 83 91 118 130 130 147 163 176 176 165 138 166 187 173 178 175 142 166 92

Offentlig adgang

Se alle

10 artikler

2 artikler

tilgængelige

ikke tilgængelige

Baseret på krav i forbindelse med finansiering

Medforfattere

Lars OlsenDepartment of Drug Design and Pharmacology, University of CopenhagenBekræftet mail på novozymes.com
Vasanthanathan PoongavanamUppsala UniversityBekræftet mail på kemi.uu.se
Carsten Uhd NielsenDepartment of Physics, Chemistry and Pharmacy, Faculty of Sciences, University of Southern DenmarkBekræftet mail på sdu.dk
Søren BrunakProfessor of Disease Systems Biology, University of CopenhagenBekræftet mail på cpr.ku.dk
Birger BrodinProfessor, CNS drug delivery, University of CopenhagenBekræftet mail på sund.ku.dk
Marco van de WeertAssociate Professor in Biologics formulation, University of CopenhagenBekræftet mail på sund.ku.dk
Lars HemmingsenDepartment of Chemistry, University of CopenhagenBekræftet mail på chem.ku.dk
R. Stan BrownProfessor of Chemistry, Queen's UniversityBekræftet mail på chem.queensu.ca
Michael GajhedeProfessor i proteinkrystallografi, Københavns UniversitetBekræftet mail på sund.ku.dk
Anders Skov KristensenUniversity of CopenhagenBekræftet mail på sund.ku.dk
Kasper B. HansenAssociate Professor, University of MontanaBekræftet mail på mso.umt.edu
Tudor OpreaVP, Translational Informatics, Roivant Discovery SciencesBekræftet mail på roivant.com
Qiyuan LiSchool of Medicine, Xiamen UniversityBekræftet mail på xmu.edu.cn
Henrik LeffersSenior Scientist, University of Copenhagen, Denmark. henrik@leffers.proBekræftet mail på leffers.pro
Patrik RydbergAssociate Director, Computational Chemmistry, Optibrium Ltd.Bekræftet mail på optibrium.com
Jukka Rantanen, professor PhDUniversity of CopenhagenBekræftet mail på sund.ku.dk
Hans Bräuner-OsborneProfessor of Molecular Pharmacology, University of CopenhagenBekræftet mail på sund.ku.dk
Vignir IsbergSenior Department Manager, NovozymesBekræftet mail på vignir.org
David N. CooperProfessor of Human Molecular Genetics, Cardiff University, UKBekræftet mail på cardiff.ac.uk
Peter BrossResearch Unit for Molecular Medicine, Aarhus University HospitalBekræftet mail på clin.au.dk

Følg

Flemming Steen Jørgensen

Professor, Department of Drug Design and Pharmacology, University of Copenhagen

Bekræftet mail på sund.ku.dk

Molecular modelling computational chemistry structure-activity relationship


Titel Sortér efter henvisninger Sortér efter årstal Sortér efter titel	Citeret af Citeret af	År
Study on the binding of Thioflavin T to β-sheet-rich and non-β-sheet cavities M Groenning, L Olsen, M van de Weert, JM Flink, S Frokjaer, ... Journal of structural biology 158 (3), 358-369, 2007	272	2007
Prediction methods and databases within chemoinformatics: emphasis on drugs and drug candidates SÓ Jónsdóttir, FS Jørgensen, S Brunak Bioinformatics 21 (10), 2145-2160, 2005	136	2005
Evaluation and comparison of 3D-QSAR CoMSIA models for CDK1, CDK5, and GSK-3 inhibition by paullones C Kunick, K Lauenroth, K Wieking, X Xie, C Schultz, R Gussio, ... Journal of Medicinal Chemistry 47 (1), 22-36, 2004	134	2004
GABAA receptor agonists, partial agonists, and antagonists. Design and therapeutic prospects P Krogsgaard-Larsen, B Frølund, FS Joergensen, A Schousboe Journal of medicinal chemistry 37 (16), 2489-2505, 1994	130	1994
A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein− ligand binding affinities GE Terp, BN Johansen, IT Christensen, FS Jørgensen Journal of medicinal chemistry 44 (14), 2333-2343, 2001	127	2001
Classification of cytochrome P450 1A2 inhibitors and noninhibitors by machine learning techniques P Vasanthanathan, O Taboureau, C Oostenbrink, NPE Vermeulen, ... Drug Metabolism and Disposition 37 (3), 658-664, 2009	111	2009
Mutational mapping and modeling of the binding site for (S)-citalopram in the human serotonin transporter J Andersen, L Olsen, KB Hansen, O Taboureau, FS Jørgensen, ... Journal of Biological Chemistry 285 (3), 2051-2063, 2010	106	2010
hERG classification model based on a combination of support vector machine method and GRIND descriptors Q Li, FS Jørgensen, T Oprea, S Brunak, O Taboureau Molecular pharmaceutics 5 (1), 117-127, 2008	104	2008
Structural differences of matrix metalloproteinases with potential implications for inhibitor selectivity examined by the GRID/CPCA approach GE Terp, G Cruciani, IT Christensen, FS Jørgensen Journal of medicinal chemistry 45 (13), 2675-2684, 2002	102	2002
Prediction of cytochrome P450 mediated metabolism L Olsen, C Oostenbrink, FS Jørgensen Advanced drug delivery reviews 86, 61-71, 2015	93	2015
Identification of a gene on chromosome 12q22 uniquely overexpressed in chronic lymphocytic leukemia AM Buhl, J Jurlander, FS Jørgensen, AM Ottesen, JB Cowland, ... Blood 107 (7), 2904-2911, 2006	92	2006
Prediction of pH-dependent aqueous solubility of druglike molecules NT Hansen, I Kouskoumvekaki, FS Jørgensen, S Brunak, SO Jonsdottir Journal of chemical information and modeling 46 (6), 2601-2609, 2006	86	2006
Virtual screening and prediction of site of metabolism for cytochrome P450 1A2 ligands P Vasanthanathan, J Hritz, O Taboureau, L Olsen, F Steen Jørgensen, ... Journal of chemical information and modeling 49 (1), 43-52, 2009	81	2009
Recent advances in GABA agonists, antagonists and uptake inhibitors: structure–activity relationships and therapeutic potential P KROGSGAARD-LARSEN, H HJEDS, E FALCH, FS JØRGENSEN, ... Advances in drug research 17, 381-456, 1988	79	1988
New leads of metallo-β-lactamase inhibitors from structure-based pharmacophore design L Olsen, S Jost, HW Adolph, I Pettersson, L Hemmingsen, FS Jørgensen Bioorganic & Medicinal Chemistry 14 (8), 2627-2635, 2006	67	2006
Towards an understanding of drug resistance in malaria: three-dimensional structure of Plasmodium falciparum dihydrofolate reductase by homology building T Lemcke, IT Christensen, FS Jørgensen Bioorganic & medicinal chemistry 7 (6), 1003-1011, 1999	61	1999
Cyclynes. Part 5. Pericyclynes:" exploded cycloalkanes" with unusual orbital interactions and conformational properties. MM2 and STO-3G calculations, x-ray crystal structures … KN Houk, LT Scott, NG Rondan, DC Spellmeyer, G Reinhardt, JL Hyun, ... Journal of the American Chemical Society 107 (23), 6556-6562, 1985	61	1985
Solvent diversity in polymorph screening M Allesø, F Van Den Berg, C Cornett, FS Jørgensen, B Halling-Sørensen, ... Journal of pharmaceutical sciences 97 (6), 2145-2159, 2008	60	2008
Primary structure and conformational analysis of peptide methionine—tyrosine, a peptide related to neuropeptide Y and peptide YY isolated from lamprey intestine JM CONLON, B BJØRNHOLM, FS JØRGENSEN, JH YOUSON, ... European journal of biochemistry 199 (2), 293-298, 1991	57	1991
Human peptide transporters: therapeutic applications CU Nielsen, B Brodin, FS Jørgensen, S Frokjaer, B Steffansen Expert Opinion on Therapeutic Patents 12 (9), 1329-1350, 2002	54	2002

Systemet kan ikke foretage handlingen nu. Prøv igen senere.

Artikler 1–20

Henvisninger pr. år

Dublerede henvisninger

Flettede henvisninger

Tilføj medforfattereMedforfattere

Følg denne forfatter

Citeret af

Medforfattere